Single Injection of PV-10 Being Tested in the Treatment of Advanced Melanoma

“A new study underway at Moffitt Cancer Center in Tampa, Florida, is investigating whether an intralesional injection of PV-10 (a substance derived from Rose Bengal, a staining agent that has been used to assess eye damage), is effective in reducing tumors and the spread of cancer in patients with melanoma. Early clinical trials show PV-10 can boost immune response in melanoma tumors and in the bloodstream.”


Moffitt Cancer Center Researchers Design Small Molecule to Disrupt Cancer-Causing Protein

“Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have developed a small molecule that inhibits STAT3, a protein that causes cancer. This development could impact the treatment of several tumor types, including breast, lung, prostate and others that depend on STAT3 for survival. The study appeared in the Jan. 15 online issue of Cancer Researcha publication of the American Association for Cancer Research.”


Moffitt Cancer Center Researchers Design Small Molecule to Disrupt Cancer-Causing Protein

“Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have developed a small molecule that inhibits STAT3, a protein that causes cancer. This development could impact the treatment of several tumor types, including breast, lung, prostate and others that depend on STAT3 for survival. The study appeared in the Jan. 15 online issue of Cancer Researcha publication of the American Association for Cancer Research.”


Moffitt Cancer Center Researchers Design Small Molecule to Disrupt Cancer-Causing Protein

“Researchers at Moffitt Cancer Center and colleagues at the University of South Florida have developed a small molecule that inhibits STAT3, a protein that causes cancer. This development could impact the treatment of several tumor types, including breast, lung, prostate and others that depend on STAT3 for survival. The study appeared in the Jan. 15 online issue of Cancer Researcha publication of the American Association for Cancer Research.”